Table 7 Baseline characteristics of HAM-net-registered patients who had been observed for one year (n = 346)
All patients (n = 346) | Steroid (S) group (n = 131) | Steroid- history (SH) group (n = 82) | Untreated (U) group (n = 85) | Miscella- neous (M) group (n = 48) | p value | Groups with significant difference c) | |
|---|---|---|---|---|---|---|---|
Sex: Female | 260 (75.1%) | 97 (74.0%) | 60 (73.2%) | 67 (78.8%) | 36 (75.0%) | 0.832 a) | – |
Age at baseline (year)d | 61.8 ± 10.8 | 62.1 ± 9.30 | 62.2 ± 11.7 | 61.5 ± 11.9 | 60.7 ± 11.0 | 0.875 b) | – |
Age at onset (year)d | 44.6 ± 14.8 | 47.4 ± 13.6 | 40.4 ± 15.2 | 45.0 ± 15.0 | 43.1 ± 16.0 | 0.009 b) | S > SH |
Disease durationd (Time from onset to initial interview) | 16.1 ± 11.1 | 13.9 ± 10.0 | 20.6 ± 10.8 | 14.9 ± 11.7 | 16.7 ± 11.3 | < 0.001 b) | SH > S, SH > U |
Baseline OMDSd | 5.7 ± 2.2 | 5.7 ± 1.9 | 6.5 ± 2.5 | 5.0 ± 2.1 | 5.8 ± 2.2 | < 0.001 b) | SH > S > U |
Rapid progressorse | 68 (19.7%) | 35 (26.7%) | 14 (17.1%) | 12 (14.1%) | 7 (14.6%) | 0.075 a) | – |